Aquaporin 2 Mutations in Nephrogenic Diabetes Insipidus

Autor: Anne J.M. Loonen, Nine V A M Knoers, Peter M.T. Deen, Carel H. van Os
Rok vydání: 2008
Předmět:
Vasopressin
medicine.medical_specialty
Health aging / healthy living [IGMD 5]
030232 urology & nephrology
Membrane transport and intracellular motility [NCMLS 5]
Diabetes Insipidus
Nephrogenic

Genes
Recessive

urologic and male genital diseases
Mice
Metabolism
transport and motion [NCMLS 2]

03 medical and health sciences
0302 clinical medicine
Arginine vasopressin receptor 2
Internal medicine
medicine
Animals
Humans
Genes
Dominant

Renal disorder [IGMD 9]
030304 developmental biology
Vasopressin receptor
0303 health sciences
Aquaporin 2
urogenital system
business.industry
Reabsorption
Apical membrane
medicine.disease
Nephrogenic diabetes insipidus
Renal disorders [UMCN 5.4]
Disease Models
Animal

Endocrinology
Genetic defects of metabolism [UMCN 5.1]
Nephrology
Mutation
Diabetes insipidus
business
hormones
hormone substitutes
and hormone antagonists
Zdroj: Seminars in Nephrology, 28, 252-65
Seminars in Nephrology; Vol 28
Seminars in Nephrology, 28, 3, pp. 252-65
Seminars in Nephrology
ISSN: 0270-9295
DOI: 10.1016/j.semnephrol.2008.03.006
Popis: Item does not contain fulltext Water reabsorption in the renal collecting duct is regulated by the antidiuretic hormone vasopressin (AVP). When the vasopressin V2 receptor, present on the basolateral site of the renal principal cell, becomes activated by AVP, aquaporin-2 (AQP2) water channels will be inserted in the apical membrane, and in this fashion, water can be reabsorbed from the pro-urine into the interstitium. The essential role of the vasopressin V2 receptor and AQP2 in the maintenance of body water homeostasis became clear when it was shown that mutations in their genes cause nephrogenic diabetes insipidus, a disorder in which the kidney is unable to concentrate urine in response to AVP. This review describes the current knowledge on AQP2 mutations in nephrogenic diabetes insipidus.
Databáze: OpenAIRE